BioCentury
ARTICLE | Clinical News

PVX-410: Ph Ib started

December 6, 2016 8:02 PM UTC

OncoPep said investigators began an open-label, U.S. Phase Ib trial to evaluate intramuscular PVX-410 plus IV durvalumab (MEDI4736) in about 20 patients. Patients will receive PVX-410 every 2 weeks an...